GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Group Co Ltd (SZSE:300723) » Definitions » Cyclically Adjusted PS Ratio

ApicHope Pharmaceutical Group Co (SZSE:300723) Cyclically Adjusted PS Ratio : 11.96 (As of Jun. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Group Co Cyclically Adjusted PS Ratio?

As of today (2025-06-04), ApicHope Pharmaceutical Group Co's current share price is ¥51.67. ApicHope Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 was ¥4.32. ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is 11.96.

The historical rank and industry rank for ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300723' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.65   Med: 5.62   Max: 11.5
Current: 11.5

During the past 12 years, ApicHope Pharmaceutical Group Co's highest Cyclically Adjusted PS Ratio was 11.50. The lowest was 3.65. And the median was 5.62.

SZSE:300723's Cyclically Adjusted PS Ratio is ranked worse than
93.5% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs SZSE:300723: 11.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ApicHope Pharmaceutical Group Co's adjusted revenue per share data of for the fiscal year that ended in Dec24 was ¥3.211. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥4.32 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


ApicHope Pharmaceutical Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ApicHope Pharmaceutical Group Co Cyclically Adjusted PS Ratio Chart

ApicHope Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5.35 6.72 3.95

ApicHope Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3.95 -

Competitive Comparison of ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.


;
;

ApicHope Pharmaceutical Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=51.67/4.32
=11.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ApicHope Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec24 is calculated as:

For example, ApicHope Pharmaceutical Group Co's adjusted Revenue per Share data for the fiscal year that ended in Dec24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=3.211/114.8925*114.8925
=3.211

Current CPI (Dec24) = 114.8925.

ApicHope Pharmaceutical Group Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201512 3.152 100.600 3.600
201612 3.845 102.600 4.306
201712 4.143 104.500 4.555
201812 3.280 106.500 3.538
201912 3.799 111.200 3.925
202012 3.862 111.500 3.980
202112 5.183 113.108 5.265
202212 5.271 115.116 5.261
202312 5.542 114.781 5.547
202412 3.211 114.893 3.211

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ApicHope Pharmaceutical Group Co  (SZSE:300723) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


ApicHope Pharmaceutical Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of ApicHope Pharmaceutical Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ApicHope Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 27, Huanyu 1st Road, 15-19th Floor, Yunrun Building, Guangzhou International Bio-Island, Huangpu District. Guangdong Province, Guangzhou, CHN, 510320
ApicHope Pharmaceutical Group Co Ltd is engaged in Research and Development: pharmaceuticals; transfer of pharmaceutical technology; import and export of goods and technology; and leasing of non-residential real estate.
Executives
Yang De Ming Independent director
Zhang Ming Yuan Secretary Dong
Zhang Ying Ying Supervisors
Li Han Dong Director
Ke Rui Yu Supervisors
Zhang Hui Xing Executives

ApicHope Pharmaceutical Group Co Headlines

No Headlines